Moderna, Inc.(MRNA) Q3
EPS: 0.38 USD; Forecast -1.1 USD
Revenue: 1.31B USD; Forecast 890.25M USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-11-06